Φορτώνει......
Consequences of Performing Parallel Dose Finding Trials in Heterogeneous Groups of Patients
Patient heterogeneity, in which patients can be grouped by risk of toxicity, is a design challenge in early phase dose finding trials. Carrying out independent trials for each group is a readily available approach for dose finding. However, this often leads to dose recommendations that violate the k...
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | JNCI Cancer Spectr |
|---|---|
| Κύριοι συγγραφείς: | , , |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
Oxford University Press
2019
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6555302/ https://ncbi.nlm.nih.gov/pubmed/31206097 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jncics/pkz013 |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|